Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
2.
Nat Med ; 27(9): 1607-1613, 2021 09.
Article in English | MEDLINE | ID: covidwho-1290003

ABSTRACT

Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients-247 home-isolated and 65 hospitalized-comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of initial illness, increased convalescent antibody titers and pre-existing chronic lung disease. We found that 52% (32/61) of home-isolated young adults, aged 16-30 years, had symptoms at 6 months, including loss of taste and/or smell (28%, 17/61), fatigue (21%, 13/61), dyspnea (13%, 8/61), impaired concentration (13%, 8/61) and memory problems (11%, 7/61). Our findings that young, home-isolated adults with mild COVID-19 are at risk of long-lasting dyspnea and cognitive symptoms highlight the importance of infection control measures, such as vaccination.


Subject(s)
Antibodies, Viral/blood , COVID-19/complications , COVID-19/pathology , Cognitive Dysfunction/virology , Dyspnea/virology , Fatigue/virology , Adolescent , Adult , Ageusia/virology , Anosmia/virology , Child , Child, Preschool , Female , Humans , Infant , Male , Middle Aged , Norway , Patient Isolation , Prospective Studies , SARS-CoV-2 , Severity of Illness Index , Young Adult
3.
Tidsskr Nor Laegeforen ; 140(11)2020 08 18.
Article in English, Norwegian | MEDLINE | ID: covidwho-724858

ABSTRACT

As the pandemic has been unfolding, reports have emerged of a relatively high incidence of coagulopathy and thromboembolic events in connection with COVID-19 infections. Raised awareness surrounding this issue, and appropriate antithrombotic prophylaxis and treatment, are therefore important for this group of patients.


Subject(s)
Coronavirus Infections/complications , Pneumonia, Viral/complications , Venous Thromboembolism/prevention & control , Venous Thromboembolism/therapy , Anticoagulants/therapeutic use , Betacoronavirus , COVID-19 , Humans , Pandemics , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL